Beta Bionics Chief Commercial Officer Mark Hopman disposes of 36,870 common shares worth $680,723.44
BBNX•Insider share sale reported
- Beta Bionics Chief Commercial Officer Mark Hopman sold 36,870 common shares on Sep. 9, 2026 at $18.46 per share.
- After the transaction, his direct holding stood at 87,157 shares.
